Calendar

Week of Apr 27, 2026

Apr 28, 2026phase 2 completion86d agoTianjin Medical University Cancer Institute and Hospital — AG [gemcitabine + nab-paclitaxel] (Phase II Trial Completion)AG [gemcitabine + nab-paclitaxel]

Therapy area: Oncology. Indication: Pancreatic Cancer

full page →AG [gemcitabine + nab-paclitaxel] →source: globaldata

Apr 28, 2026phase 2 completion86d agoHackensack Meridian Health Inc — carboplatin (Phase II Trial Completion)Carboplatin Pfizer

Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma

full page →Carboplatin Pfizer →source: globaldata

Apr 28, 2026phase 2 completion86d agoTamilnadu Government Dental College and Hospital — metformin (Phase II Trial Completion)metformin

Therapy area: Mouth and Dental Disorders. Indication: Unspecified Mouth and Dental Disorders

full page →metformin →source: globaldata

Apr 28, 2026phase 2 completion86d agoArdabil University of Medical Sciences — chorionic gonadotropin (Phase II Trial Completion)chorionic gonadotropin

Therapy area: Women's Health. Indication: Female Infertility

full page →chorionic gonadotropin →source: globaldata

Apr 28, 2026phase 2 completion86d agoShanghai Pulmonary Hospital — undisclosed programmed cell death protein 1 inhibitor (Phase II Trial Completion)undisclosed programmed cell death protein 1 inhibitor

Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer

full page →undisclosed programmed cell death protein 1 inhibitor →source: globaldata

Apr 28, 2026phase 2 completion86d agoAl-Mustansiriya University — platelet rich fibrin (Phase II Trial Completion)platelet rich fibrin

Therapy area: Mouth and Dental Disorders. Indication: Periodontitis

full page →platelet rich fibrin →source: globaldata

Apr 28, 2026phase 2 completion86d agoWest China Hospital of Stomatology — dexamethasone (Phase II Trial Completion)dexamethasone

Therapy area: Mouth and Dental Disorders. Indication: Aphthous Ulcers (Canker Sores)

full page →dexamethasone →source: globaldata

Apr 28, 2026phase 2 completion86d agoUniversity of Sao Paulo General Hospital — iloprost (Phase II Trial Completion)iloprost

Therapy area: Cardiovascular. Indication: Pulmonary Arterial Hypertension

full page →iloprost →source: globaldata

Apr 28, 2026phase 2 initiation86d agoSRM Medical College Hospital and Research Centre — dexmedetomidine (Phase II Trial Initiation)dexmedetomidine

Therapy area: Central Nervous System. Indication: Unspecified Central Nervous System Disorders

full page →dexmedetomidine →source: globaldata

Apr 28, 2026phase 2 initiation86d agoFudan University Shanghai Cancer Center — YZJ-2440 (Phase II Trial Initiation)YZJ-2440

Therapy area: Oncology. Indication: Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Solid Tumor

full page →YZJ-2440 →source: globaldata

Apr 28, 2026phase 2 initiation86d agoShanxi Ruifulai Pharmaceutical Co Ltd — brexpiprazole (Phase II Trial Initiation)BREXPIPRAZOLE

Therapy area: Central Nervous System. Indication: Schizophrenia

full page →BREXPIPRAZOLE →source: globaldata

Apr 28, 2026phase 2 initiation86d agoAP Biosciences Inc — B-1962 (Phase II Trial Initiation)B-1962

Therapy area: Oncology. Indication: Solid Tumor

full page →B-1962 →source: globaldata

Apr 28, 2026phase 2 initiation86d agoRise Biopharmaceutical Ltd — RP-72 (Phase II Trial Initiation)RP-72

Therapy area: Oncology. Indication: Metastatic Pancreatic Cancer, Pancreatic Cancer

full page →RP-72 →source: globaldata

Apr 28, 2026phase 2 initiation86d agoInstitute of Medical Sciences of the Banaras Hindu University — ropivacaine (Phase II Trial Initiation)ropivacaine ER

Therapy area: Central Nervous System, Respiratory. Indication: Pleural Disease, Post-Operative Pain

full page →ropivacaine ER →source: globaldata

Apr 28, 2026phase 2 initiation86d agoTianjin Lisheng Pharmaceutical Co Ltd — dexamethasone acetate (Phase II Trial Initiation)dexamethasone acetate

Therapy area: Immunology, Respiratory. Indication: Allergic Rhinitis, Inflammation, Transplant Rejection

full page →dexamethasone acetate →source: globaldata

Apr 28, 2026phase 2 3 completion86d agoFaculty of Medicine Siriraj Hospital Mahidol University — bevacizumab (Phase II/III Trial Completion)bevacizumab

Therapy area: Non Malignant Disorders. Indication: Hemangiomas

full page →bevacizumab →source: globaldata

Apr 28, 2026phase 2 3 completion86d agoFaculty of Medicine, Srinakharinwirot University — tranexamic acid (Phase II/III Trial Completion)tranexamic acid

Therapy area: Musculoskeletal Disorders. Indication: Osteoarthritis

full page →tranexamic acid →source: globaldata

Apr 28, 2026phase 2 3 initiation86d agoAyurved Mahavidyalaya and Shri Sant Eknath Rugnalaya. Shevgaon, — ayurvedic medicine (Phase II/III Trial Initiation)ayurvedic medicine

Therapy area: Ear Nose Throat Disorders. Indication: Acute Tonsillitis

full page →ayurvedic medicine →source: globaldata

Apr 28, 2026phase 3 completion86d agoGovernment Stanley Medical College Hospital — tenecteplase (Phase III Trial Completion)tenecteplase

Therapy area: Genito Urinary System, Infectious Disease. Indication: End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), Unspecified Bacterial Infections

full page →tenecteplase →source: globaldata

Apr 28, 2026phase 3 completion86d agoAll India Institute of Medical Sciences — (iron + folic acid) (Phase III Trial Completion)(iron + folic acid)

Therapy area: Hematological Disorders. Indication: Anemia, Iron Deficiency Anemia

full page →(iron + folic acid) →source: globaldata

Apr 28, 2026phase 3 completion86d agoSun Yat-sen Memorial Hospital — capecitabine (Phase III Trial Completion)capecitabine

Therapy area: Oncology. Indication: Nasopharyngeal Cancer

full page →capecitabine →source: globaldata

Apr 28, 2026phase 3 results86d agoBanook Group — brepocitinib tosylate (Phase III Trial Results)brepocitinib tosylate

Therapy area: Musculoskeletal Disorders. Indication: Dermatomyositis

full page →brepocitinib tosylate →source: globaldata

Apr 28, 2026phase iv trial initiation86d agoDr Susheela Tiwari Government Hospital — ormeloxifene (Phase IV Trial Initiation)ormeloxifene

Therapy area: Central Nervous System, Non Malignant Disorders. Indication: Benign Tumor, Mastalgia (Breast Pain)

full page →ormeloxifene →source: globaldata

Apr 28, 2026phase iv trial initiation86d agoRajendra Institute of Medical Sciences — levobupivacaine (Phase IV Trial Initiation)levobupivacaine

Therapy area: Central Nervous System. Indication: Pain

full page →levobupivacaine →source: globaldata

Apr 28, 20268k filing86d ago$JNJ — JOHNSON & JOHNSON (JNJ) — 8-K filing

Items: 5.07, 9.01

Week of Apr 27, 2026